RNA

Atrium TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

RNA vs peer average

95/100

RNA vs. peer average (A vs. D)

Grade spread

B 1 · D 4 · F 3

Graded peers loaded

Coverage

8 graded

100% of tracked

Peer overview

CGEN is the first available peer comparator.

Loose same-sector, similar-market-cap biotechnology peer; limited direct read-through to Atrium's RNA cardiology programs.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerCGENCompugen

RNA

Atrium Therapeutics

CGEN

Compugen

Grade

Momentum

Value

Sentiment

100

Setup Bias

Net —

Market Cap

Posture

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs CGEN

RNA / CGEN

Grade Position

Above peers

RNA vs. peer average (A vs. D)

95/100

Momentum

CGEN

Value

RNA

Sentiment

100

RNA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs RNA

80/100

20/100

20/100

Organogenesis Holdings Inc Class A Common

40/100

VOGX

Vogenx Inc Common

20/100

CGEN is the first peer returned for this comparison set.